Search Results 301-310 of 9773 for Primary biliary cholangitis
The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ...
Primary sclerosing cholangitis is a major risk factor for cirrhosis, colon cancer and cholangiocarcinoma. After diagnosis, many patients have a liver transplant ...
Primary sclerosing cholangitis, Primary biliary cholangitis, Liver cancer · Cadman L. Leggett, M.D.. Rochester, MN ...
tocellular carcinoma, Cirrhosis, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Liver ...
ar carcinoma, Cirrhosis, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Acute liver ...
Primary biliary cirrhosis is a serious, life-threatening, bile acid related liver disease of unknown cause. Without treatment, it frequently progresses to liver ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
... Cirrhosis, Hepatitis C, Hepatitis B, No...nalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis ...
Elafibranor is used in combination with ursodeoxycholic acid (UDCA) to treat primary biliary cholangitis (PBC) in patients who have received UDCA but did not ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.